D-Erythro-dihydrosphingosine

• UNSPSC Description:

  D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity.

• Target Antigen:

  Endogenous Metabolite; Phospholipase

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/D-Erythro-dihydrosphingosine.html

• Purity:

  99.55

• Solubility:

  DMSO : 10 mg/mL (ultrasonic;warming;heat to 60°C)|Ethanol : 50 mg/mL (ultrasonic)

• Smiles:

  CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO

• Molecular Weight:

  301.51

• References & Citations:

  [1]Nakamura H, et al. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol. 2004 Jan 19;484(1):9-17.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  764-22-7